Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Varian Medical Systems Acquires Assets Of IKOEmed And IKOEtech; Acquisition To Add Software For Accelerating Radiotherapy Treatment Planning
Varian Medical Systems, Inc., (NYSE: VAR) announced it has acquired the assets of Houston-based IKOEmed and IKOEtech, privately-owned suppliers of software used in the planning of radiotherapy and radiosurgery treatments. The acquisition enables Varian to offer hospitals and clinics an additional software tool to automate and accelerate the most time-consuming portion of the treatment planning process. Varian is paying approximately $2.2 million plus an additional amount based on achievement of specified milestones to acquire the IKOE assets.
generic viagra online
New Broad-Spectrum Vaccine To Prevent Cervical Cancer Induces Strong Responses In Animals
Mice and rabbits immunized with a multimeric-L2 protein vaccine had robust antibody responses and were protected from infection when exposed to human papillomavirus (HPV) type 16 four months after vaccination, according to a new study published in the May 26 online issue of the Journal of the National Cancer Institute.
News of the day
MorphoSys Reports Filing For Phase 1b/2a Trial For Its Lead Program MOR103 In Rheumatoid Arthritis
MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) today announced that the Company has submitted an application for the authorization of a phase 1b/2a clinical study in patients with active rheumatoid arthritis (RA) for its lead drug MOR103, a fully human HuCAL-derived monoclonal antibody directed against Granulocyte Macrophage-Colony Stimulating Factor. The trial, which will be conducted in multiple centers in several European countries, is expected to enroll 135 patients in total beginning in the second half of 2009. Additionally, the Company today reported positive results from the phase 1 clinical study for MOR103 in healthy volunteers. The results of this study indicate that MOR103 is generally safe and well tolerated at all doses administered.
Health Insurance

AP/Los Angeles Times Examines Haiti's Fight Against HIV

The AP/Los Angeles Times examines Haiti"s success at reducing the number of people infected with HIV/AIDS in the country through the work of the "nonprofit groups, Boston-based Partners in Health (PIH) and Port-au-Prince"s GHESKIO, widely considered to be the world"s oldest AIDS clinic." Haiti"s HIV rate is "lower than the Bahamas, Guyana and Suriname, and much lower than sub-Saharan Africa, where the rate averages about 5 percent but spikes to 24 percent in Botswana and 33 percent in Swaziland," according to the newspaper. Still, as the article notes, Haiti"s "crisis is far from over," with varying infection rates across remote regions in the country. "From 1993 to 2003, only pregnant women were tested, and their rate of infection dropped from 6.2 percent to 3.1 percent, according to GHESKIO and national health surveys," the newspaper writes. "Researchers now test men and women aged 15 to 49, and the official rate is 2.2 percent, according to UNAIDS." The article details the early successes of PIH and GHESKIO and highlights such programs as PIH"s ""accompagnateur" program, in which local workers including HIV patients are paid to help the newly diagnosed adhere to physically taxing medication regimens and prevention measures," and "GHESKIO"s work, such as distributing phone cards to patients to keep in closer touch with their doctors." The article also notes, "Thanks in large part to UNAIDS, which awarded Haiti its first grant in 2002, and $420 million from the U.S. President"s Emergency Plan for AIDS Relief, or PEPFAR, an estimated 18,000 people are on AIDS drugs, most of them administered free through GHESKIO and PIH" (Katz, 7/5). This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009